| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enanta Pharmaceuticals Inc (ENTA) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. ENTA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $13.16M | - | |
| Other | 371.4K | $5.70M | - | |
| Other | 38.3K | $588.0K | - | |
| Other | 30.6K | $469.7K | - | |
| Other | 21.8K | $334.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2020 | Mellett Paul J63 | Treasurer And CFO | Sale+OE | 10,000 | $60.88 | $608,799.59 | -11.0% | |
| Mar 11, 2019 | Carter Bruce L A | Director | Sale+OE | 1,546 | $99.16 | $153,301.36 | -100% | |
| Mar 4, 2019 | Golumbeski George | Director | Sale+OE | 9,280 | $103.65 | $961,897.06 | -100% | |
| Mar 1, 2019 | Or Yat Sun59 | Sr. VP &CSO | Sell | 10,000 | $103.53 | $1,035,320.21 | -1.6% | |
| Feb 13, 2019 | Gardiner Nathaniel S. | Sr. VP &General Counsel | Sell | 3,270 | $95.28 | $311,562.33 | -12.0% | |
| Feb 12, 2019 | Or Yat Sun59 | Sr. VP &CSO | Sale+OE | 33,981 | $89.52 | $3,041,910.29 | -2.1% | |
| Feb 12, 2019 | Golumbeski George | Director | Sale+OE | 13,500 | $90.06 | $1,215,853.49 | -100% | |
| Feb 12, 2019 | Carter Bruce L A | Director | Sale+OE | 7,734 | $90.01 | $696,101.83 | -100% | |
| Oct 1, 2018 | Ocain Tim | Senior Vice President | Sale+OE | 25,000 | $83.64 | $2,090,903.40 | -28.8% | |
| Sep 20, 2018 | Adda Nathalie80 | Sr. VP &Chief Medical Officer | Sale+OE | 4,155 | $95.32 | $396,036.11 | -28.9% |